MDNA-19

N/A

Report date: 2023/05/22 10:17:43

Base Information

Drug NameMDNA-19
Drug Alias NameMDNA-19
ClassificationBiologics
Mechanisms of ActionNatural killer cells stimulantsCytotoxic T lymphocytes stimulantsInterleukin-2 receptor beta chain agonists
TargetsInterleukin-2 receptor beta chain
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMedicenna Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A